U.S. markets open in 13 minutes

DiaMedica Therapeutics Inc. (DMAC)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
6.47-0.29 (-4.29%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close6.76
Open6.70
Bid6.26 x 2200
Ask7.50 x 1000
Day's Range6.25 - 6.88
52 Week Range3.77 - 10.88
Volume237,133
Avg. Volume118,193
Market Cap121.547M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.79
Earnings DateAug 09, 2021 - Aug 13, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est25.33
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • ACCESSWIRE

    DiaMedica Therapeutics, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / May 6, 2021 / DiaMedica Therapeutics, Inc. (NASDAQ:DMAC) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 6, 2021 at 8:00 AM Eastern Time.

  • DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2021 Financial Results
    Business Wire

    DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2021 Financial Results

    DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, today provided a business update and financial results for the quarter ended March 31, 2021. DiaMedica will host a conference call Thursday, May 6, 2021, at 7:00 a.m. Central Time to discuss its business update and first quarter financial results.

  • DiaMedica Therapeutics to Report First Quarter 2021 Financials and Provide a Business Update May 6, 2021
    Business Wire

    DiaMedica Therapeutics to Report First Quarter 2021 Financials and Provide a Business Update May 6, 2021

    DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, today announced that its first quarter 2021 financial results will be released after the markets close on Wednesday, May 5th. DiaMedica will host a live conference call on Thursday, May 6th at 7:00 AM Central Time to discuss its business update and financial results.